|
Monday, February 28 — 8:00 AM — CC 006 A/B
Click on the blue numbers in parentheses to display abstracts.
Click the  button next to any title to add to Itinerary Planner...
Section D - Gynecologic Pathology
Chaired by: Joseph Rabban and Carmen Tornos
| Time | Title and Authors | Itinerary
Planner |
| 8:00 |
The Accuracy of an Intraoperative Diagnosis of Ovarian Borderline Tumor Varies by Histologic Subtype.
(1045)
K Garg, K Shih, R Barakat, N Abu-Rustum, RA Soslow - MSKCC, New York
|  Add |
| 8:15 |
Ovarian Serous Tumors of Low Malignant Potential with Nodal Low Grade Serous Carcinoma.
(1029)
B Djordjevic, A Malpica - University of Ottawa, ON, Canada; M.D. Anderson Cancer Center, Houston, TX
| Add |
| 8:30 |
Does Subdividing High Grade Ovarian Serous Carcinoma into Silverberg Grade 2 and 3 Have Biologic Validity?
(1038)
L Feeley, AM Mulligan, C Yao, H Chen, B Gilks, P Boutros, B Clarke - St Michaels Hospital, Toronto, Canada; Ontario Institute for Cancer Research, Toronto, Canada; Uinversity of British Columbia, Vancouver, Canada; UHN, Toronto, Canada
| Add |
| 8:45 |
The Significance of the Pattern of Invasion in High Grade Serous Carcinoma of the Ovary.
(1114)
DM Patel, EG Silva, C Walsh - Cedars-Sinai Medical Center, Los Angeles, CA
| Add |
| 9:00 |
Embryonic Stem Cell Factor Sox2 in Ovarian Carcinomas . Significant Association with More Poorly Differentiated Carcinomas and Longer Overall Survival in a Subgroup of Stage II-IV High-Grade Serous Carcinomas.
(1135)
A Staebler, D Pham, V Scheble, P Bareiss, H Neubauer, C Lengerke, S Perner, T Fehm - University of Tuebingen, Germany; University Hospital of Bonn, Germany
| Add |
| 9:15 |
Morphologic Patterns Associated with BRCA1 and BRCA2 Genotype.
(1132)
R Soslow, G Han, N Olvera, D Levine - Memorial Sloan-Kettering Cancer Center, New York, NY
| Add |
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION I
| |
| 11:00 |
Germline BRCA1 Mutation Positive Ovarian Cancer Exhibits a Distinctive Highly Specific Phenotype.
(1043)
M Fujiwara, A Felberg, AS Whittemore, VM McGuire, TA Longacre - Stanford University School of Medicine, CA
| Add |
| 11:15 |
Revised Histologic Criteria for Ovarian Carcinoma Cell Type Show Improved Correlation with Genotype and Protein Expression Profile.
(1061)
Y Karamurzin, M Leitao, D Chiappetta, D Marshal, R Soslow - Memorial Sloan-Kettering Cancer Center, New York, NY
| Add |
| 11:30 |
Clinicopathological Significance of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma.
(1096)
D Maeda, T-L Mao, M Fukayama, T-L Wang, I-M Shih - Graduate School of Medicine, The University of Tokyo, Japan; National Taiwan University Hospital, and College of Medicine, Taipei, Taiwan; Johns Hopkins Medical Institutions, Baltimore, MD
| Add |
| 11:45 |
Factors Influencing Accuracy of Frozen Section Diagnosis of Ovarian Mucinous Tumors; a Review of 100 Cases.
(1054)
B Harmon, S Hwang, T Parker, M Pearl, C Tornos - Stony Brook University Medical Center, NY
| Add |
|
|
